Therefore, we decided to investigate the role of CCL5 through extended clinical follow ups of stroke patients by measuring the CCL5 concentration at different time intervals, <4.5 h, 24 h and the seventh day, and compare them with the control group. The gene discussed is CCL5; the disease is stroke disorder.